The treatment effect of murine Interleukin-12 in mouse asthma
Guang Yang
Abstract
Guang Yang
Abstract
Objective To observe the effects of Intranasal Immunization with miurine interleukin-12 (mIL-12) on the antigen induced Airway inflammation and T helper cell subsets in mouse asthma models. Methods Construct pSEC:mIL-12 vector and transform to NZ9000,mIL-12 was expressed in lactis by the induction with Nisin.After centrifugation,Concentration of bacterial supernatants was Intranasal administration with murine.Fifty mice were divided into 5 groups by digits table:(A) control group;(B) phosphate-buffered saline (PBS)group;(C) wild Lactococcus lactis group;(D) Recombinant IL-12 group; (E) Recombinant Lactococcus lactis group.Except A group,Mice of the other groups were peritoneally sensitized with ovalbum (OVA,100μg/mouse) in three times on 1,7 and 14 days,and challenged by inhalation of 2% OVA one times a day from day 20 to 26,on day 1,2,3,14,19,20 and 21,B,C,E groups was administrated by nasal drip with 10μl of PBS,wild laetis(a total of 5 × 10~8CFU)and Recombinant lactis (a total of 5 × 10~8CFU).On day 20,21 and 22 D group was administrated by nasal drip with 3ng of Recombinant IL-12.All group were sacrificed on day 28.The concentration of Interleukin-4 (IL-4) and interferon-γ(IFN-γ) in bronchoalveolar lavage fluid (BALF) was measured by enzyme-linked immunosorbant assay(ELISA).A count of eosinophils (EOS) were quantified by cell count and histopathological analysis. Results Protein level of IL-12 can be secreted by Lactococcus lactis in higher expression.The concentration of EOS of groups(A-E) in BALF was 0.51±0.23 × 10~4 cell/ml,21.32±5.71 × 10~4 cell./ml,22.84±6.16 × 10~4 cell/ml,2.15±0.63 × 10~4 cell/ml,2.62±0.73 × 10~4 cell/ml,respectively;the concentration of IL-4 was 68.43±9.08 pg/ml,332.13±61.36 pg/ml,324.65±57.27 pg/ml,121.25±35.55 pg/ml,114.22±15.70 pg/ml,respectively;the concentration of IFN-γ was 110.28±12.19 pg/ml,56.25±12.08 pg/ml,70.36± 8.27 pg/ml,166.11±57.12 pg/ml,171.75±60.90 pg/ml,respectively.There were significant diffirence in the concentration of EOS,IL-4,IFN-γ of groups B and C compared with group A,respectively(P0.01). There were statistical diffirence in the concentration of EOS,IL-4,IFN-γof groups D and E compared with group B and C,respectively (P0.01).There were no significant change in EOS,IL-4,IFN-γ between group D and E.The histopathological results shows that in the intranasal administration with recombinant IL-12 groups,the infiltration of inflammatory cell was markedly reduced and the damage of airway epithelium was alleviated.Conclusion Intranasal administration recombinant IL-12 can reduce the side effect by system used.The molecular mechanisms by intranasal administration with recombinant IL-12 on murine asthma model play a indivect role by the downregulation of IL-4 expression and the upregulation of IFN-γ expression in the lung.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effects of Intranasal Immunization with miurine interleukin-12 (mIL-12) on the antigen induced Airway inflammation and T helper cell subsets in mouse asthma models. Methods Construct pSEC:mIL-12 vector and transform to NZ9000,mIL-12 was expressed in lactis by the induction with Nisin.After centrifugation,Concentration of bacterial supernatants was Intranasal administration with murine.Fifty mice were divided into 5 groups by digits table:(A) control group;(B) phosphate-buffered saline (PBS)group;(C) wild Lactococcus lactis group;(D) Recombinant IL-12 group; (E) Recombinant Lactococcus lactis group.Except A group,Mice of the other groups were peritoneally sensitized with ovalbum (OVA,100μg/mouse) in three times on 1,7 and 14 days,and challenged by inhalation of 2% OVA one times a day from day 20 to 26,on day 1,2,3,14,19,20 and 21,B,C,E groups was administrated by nasal drip with 10μl of PBS,wild laetis(a total of 5 × 10~8CFU)and Recombinant lactis (a total of 5 × 10~8CFU).On day 20,21 and 22 D group was administrated by nasal drip with 3ng of Recombinant IL-12.All group were sacrificed on day 28.The concentration of Interleukin-4 (IL-4) and interferon-γ(IFN-γ) in bronchoalveolar lavage fluid (BALF) was measured by enzyme-linked immunosorbant assay(ELISA).A count of eosinophils (EOS) were quantified by cell count and histopathological analysis. Results Protein level of IL-12 can be secreted by Lactococcus lactis in higher expression.The concentration of EOS of groups(A-E) in BALF was 0.51±0.23 × 10~4 cell/ml,21.32±5.71 × 10~4 cell./ml,22.84±6.16 × 10~4 cell/ml,2.15±0.63 × 10~4 cell/ml,2.62±0.73 × 10~4 cell/ml,respectively;the concentration of IL-4 was 68.43±9.08 pg/ml,332.13±61.36 pg/ml,324.65±57.27 pg/ml,121.25±35.55 pg/ml,114.22±15.70 pg/ml,respectively;the concentration of IFN-γ was 110.28±12.19 pg/ml,56.25±12.08 pg/ml,70.36± 8.27 pg/ml,166.11±57.12 pg/ml,171.75±60.90 pg/ml,respectively.There were significant diffirence in the concentration of EOS,IL-4,IFN-γ of groups B and C compared with group A,respectively(P0.01). There were statistical diffirence in the concentration of EOS,IL-4,IFN-γof groups D and E compared with group B and C,respectively (P0.01).There were no significant change in EOS,IL-4,IFN-γ between group D and E.The histopathological results shows that in the intranasal administration with recombinant IL-12 groups,the infiltration of inflammatory cell was markedly reduced and the damage of airway epithelium was alleviated.Conclusion Intranasal administration recombinant IL-12 can reduce the side effect by system used.The molecular mechanisms by intranasal administration with recombinant IL-12 on murine asthma model play a indivect role by the downregulation of IL-4 expression and the upregulation of IFN-γ expression in the lung.
Key concepts: Lactococcus lactis, Recombinant DNA, Nasal administration, Bronchoalveolar lavage, Immunology, Nisin, Interleukin, Molecular biology